Ad is loading...
AIM
Price
$0.21
Change
-$0.00 (-0.00%)
Updated
Nov 22 closing price
133 days until earnings call
SLN
Price
$7.01
Change
-$0.67 (-8.72%)
Updated
Nov 22 closing price
Ad is loading...

AIM vs SLN

Header iconAIM vs SLN Comparison
Open Charts AIM vs SLNBanner chart's image
AIM ImmunoTech
Price$0.21
Change-$0.00 (-0.00%)
Volume$367.42K
CapitalizationN/A
Silence Therapeutics
Price$7.01
Change-$0.67 (-8.72%)
Volume$1.53M
CapitalizationN/A
AIM vs SLN Comparison Chart
Loading...
AIM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
AIM vs. SLN commentary
Nov 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AIM is a StrongBuy and SLN is a Buy.

COMPARISON
Comparison
Nov 25, 2024
Stock price -- (AIM: $0.21 vs. SLN: $7.01)
Brand notoriety: AIM and SLN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AIM: 74% vs. SLN: 407%
Market capitalization -- AIM: $13.38M vs. SLN: $779.04M
AIM [@Biotechnology] is valued at $13.38M. SLN’s [@Biotechnology] market capitalization is $779.04M. The market cap for tickers in the [@Biotechnology] industry ranges from $468.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AIM’s FA Score shows that 0 FA rating(s) are green whileSLN’s FA Score has 0 green FA rating(s).

  • AIM’s FA Score: 0 green, 5 red.
  • SLN’s FA Score: 0 green, 5 red.
According to our system of comparison, SLN is a better buy in the long-term than AIM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AIM’s TA Score shows that 4 TA indicator(s) are bullish while SLN’s TA Score has 4 bullish TA indicator(s).

  • AIM’s TA Score: 4 bullish, 4 bearish.
  • SLN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both AIM and SLN are a good buy in the short-term.

Price Growth

AIM (@Biotechnology) experienced а -5.78% price change this week, while SLN (@Biotechnology) price change was -44.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.38%. For the same industry, the average monthly price growth was -4.87%, and the average quarterly price growth was +4.35%.

Reported Earning Dates

AIM is expected to report earnings on Apr 07, 2025.

SLN is expected to report earnings on May 14, 2024.

Industries' Descriptions

@Biotechnology (+2.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLN($779M) has a higher market cap than AIM($13.4M). AIM YTD gains are higher at: -52.239 vs. SLN (-59.643). AIM has higher annual earnings (EBITDA): -26.19M vs. SLN (-56.89M). SLN has more cash in the bank: 129M vs. AIM (7.2M). SLN has less debt than AIM: SLN (139K) vs AIM (3.4M). SLN has higher revenues than AIM: SLN (16.2M) vs AIM (190K).
AIMSLNAIM / SLN
Capitalization13.4M779M2%
EBITDA-26.19M-56.89M46%
Gain YTD-52.239-59.64388%
P/E RatioN/AN/A-
Revenue190K16.2M1%
Total Cash7.2M129M6%
Total Debt3.4M139K2,447%
FUNDAMENTALS RATINGS
AIM: Fundamental Ratings
AIM
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AIMSLN
RSI
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 21 days ago
90%
Declines
ODDS (%)
Bearish Trend 14 days ago
86%
Bearish Trend 5 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
77%
View a ticker or compare two or three
Ad is loading...
AIM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LICY2.150.07
+3.37%
Li-Cycle Holdings Corp
UNF200.234.16
+2.12%
Unifirst Corp
EG389.003.85
+1.00%
Everest Group Ltd
SSYS9.440.05
+0.53%
Stratasys Ltd
OTRK1.82-0.01
-0.55%
Ontrak Inc